Scinovex
article Open AccessTop 1% cited

SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor

Journal of Pharmacology and Experimental Therapeutics · 1998 · Vol. 284(2) · pp. 644–650
M Rinaldi-CarmonaFrancis BarthJ MillanJean‐Marie DerocqPierre CasellasChristian CongyDidier OustricM SarranMonsif BouaboulaBernard CalandraM PortierDavid ShireJ. C. BrelièreGérard Le Fur
Cannabis and Cannabinoid ResearchNeurotransmitter Receptor Influence on BehaviorDiet, Metabolism, and DiseaseCannabinoid receptor type 2ReceptorCannabinoid receptorCannabinoidAdenylyl cyclaseAgonistChemistryGPR18PharmacologyAntagonist

MeSH terms

Cyclic AMPAdenylyl CyclasesAdministration, OralAnimalsB-LymphocytesCamphanesCannabinoidsCyclohexanolsCricetinaeHumansLymphocyte ActivationPyrazolesReceptors, DrugRecombinant ProteinsCHO Cells
Citations
704
FWCI
37.34
field-weighted impact
References
33
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor · Scinovex